freemalaysiatoday.com

Share

freemalaysiatoday.com

 •  December 14

Their decisions on how the vaccine was rolled out could set back efforts to combat dengue by a generation, some disease experts say. CHICAGO/LONDON: When French drugmaker Sanofi published the results of clinical trials of children given its dengue vaccine two years ago, the overall findings were that it protected against the world’s biggest and...

freemalaysiatoday.com

 •  November 22

The one-pill, once-a-day combination ”provides people living with HIV the option to reduce the number of antiretrovirals they take. NEW YORK: The US Food and Drug Administration on Tuesday approved the first two-drug regimen to treat HIV, the virus that causes AIDS, aimed at lessening the side effect burden of current treatments that combine three...

freemalaysiatoday.com

 •  February 28

Sanofi, which has failed to land two big biotech acquisitions over the past year, had said it would look to strike new partnerships to spur more growth for the company. PARIS: French drugmaker Sanofi and Swiss manufacturer Lonza will invest 270 million euros (US$285 million) in a new large-scale biologics facility that will produce monoclonal...